You are viewing the "Ayana Archie | NPR" Archives

Sens. Joe Manchin and Lisa Murkowski have tested positive for COVID-19
By: Ayana Archie | NPR
Posted on:
WASHINGTON, D.C. (NPR) — Sens. Joe Manchin, a conservative Democrat from West Virginia, and Lisa Murkowski, a Republican from Alaska, have tested positive for COVID-19, they both announced Monday. “This morning I tested positive for COVID-19,” Manchin said. “I am fully vaccinated and boosted and am experiencing mild symptoms. I will isolate and follow CDC… Read More

The omicron subvariant dominating U.S. COVID-19 cases is more vaccine-resistant
By: Ayana Archie | NPR
Posted on:
WASHINGTON, D.C. (NPR) — The BA.5 omicron subvariant, which is now the most prevalent coronavirus strain in the United States, is four times more resistant to COVID-19 vaccines, according to a new study. The strain, which is considered “hypercontagious,” according to the Mayo Clinic, is more defiant against messenger RNA vaccines, which include Pfizer and… Read More

The Biden administration is capping the cost of internet for low-income Americans
By: Ayana Archie | NPR
Posted on:
WASHINGTON, D.C. (NPR) — The Biden administration says it will partner with internet providers to lower the cost of high-speed internet plans for low-income Americans, the White House announced Monday. The Affordable Connectivity Program will provide plans of at least 100 Megabits per second of speed for no more than $30. An estimated 48 million… Read More

The NFL is requiring teams to hire women or minorities as coaches for 2022 season
By: Ayana Archie | NPR
Posted on:
WASHINGTON, D.C. (NPR) — The National Football League set forth new diversity and inclusion efforts for the 2022 season at its annual owners meeting, such as requiring its 32 teams to employ a “female or a member of an ethnic or racial minority” as an offensive assistant, the league said in a statement. Candidates must… Read More

Moderna seeks FDA authorization for its COVID-19 vaccine for children under 6
By: Ayana Archie | NPR
Posted on:
WASHINGTON, D.C. (NPR) — Moderna is hoping to get the green light to administer a pediatric, low-dose COVID-19 vaccine for children ages 6 months to under 6 years of age, it said in a statement. The pharmaceutical company will submit a request to the Food and Drug Administration “in the coming weeks” for authorization for… Read More